Medication-info.com Search Menu

Ertaczo (Sertaconazole nitrate): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
20 mg/g
Drug class:
Active ingredient:

Patient information: uses, side effects, how to take - Ertaczo

What is ERTACZO cream?

ERTACZO cream is a prescription medicine used on the skin (topical) to treat athlete’s foot that is between the toes (interdigital tinea pedis) in adults and children 12 years of age and older with normal immune systems.

It is not known if ERTACZO cream is safe and effective in children younger than 12 years of age.

Before using ERTACZO cream, tell your healthcare provider about all of your medical conditions, including if you:

  • have any allergies
  • are pregnant or plan to become pregnant. It is not known if ERTACZO cream will harm your unborn baby.

  • are breastfeeding or plan to breastfeed. It is not known if ERTACZO cream passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you use ERTACZO cream.

Tell your healthcare provider about all of the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use ERTACZO cream?

  • Use ERTACZO cream exactly as your healthcare provider tells you to use it.
  • Use ERTACZO cream for the full treatment time, even if your symptoms improve.
  • If you take a bath or shower, dry the affected skin areas well before you apply ERTACZO cream.
  • Apply ERTACZO cream 2 times a day for 4 weeks to the affected skin areas between your toes and to the healthy skin around the affected areas.
  • Wash your hands after you apply ERTACZO cream.
  • Do not cover the treated skin areas with bandages unless your healthcare provider tells you to.

What are the possible side effects of ERTACZO cream?

The most common side effects of ERTACZO cream include:redness, itching, dry skin, burning, blistering, swelling, drainage, and skin tenderness at the treated skin areas. Tell your healthcare provider if you have any of these skin reactions.

These are not all the possible side effects of ERTACZO cream.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store ERTACZO cream?

  • Store ERTACZO cream at room temperature between 68°F to 77°F (20°C to 25°C).
  • Keep ERTACZO cream and all medicines out of reach of children.

General information about the safe and effective use of ERTACZO cream

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use ERTACZO cream for a condition for which it was not prescribed. Do not give ERTACZO cream to other people, even if they have the same symptoms you have. It may harm them. You can ask your healthcare provider or pharmacist for information about ERTACZO cream that is written for health professionals.

What are the ingredients in ERTACZO cream?

Active ingredient:sertaconazole nitrate

Inactive ingredients:ethylene glycol, glyceryl isostearate, glycolized saturated glycerides, light mineral oil, methylparaben, polyethylene glycol palmitostearate, polyoxyethylened saturated glycerides, purified water, and sorbic acid

Distributed by:

Coral Way Pharma, LLC

San Antonio, TX 78213 USA

Manufactured by:

DPT Laboratories, Ltd.

San Antonio, TX 78215

ERTACZO is a trademark of Lacer Pharma, LLC

141379

This Patient Information has been approved by the U.S. Food and Drug Administration.

Revised: 10/2025

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 021385 · View the label on DailyMed

Revision date stated in the text: October 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ertaczo

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Azole Antifungal
Active ingredient Sertaconazole nitrate 20 mg/g
Dosage form Cream
Route Topical
Marketing status listed in the FDA NDC Directory
Company (applicant) LACER PHARMA
FDA approval NDA 021385New Drug Application (NDA) Approved December 10, 2003
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 2 labelers list this drug on DailyMed
Packages (NDC)
Package
20 mg/g – 60 g in 1 tube / 1 in 1 carton NDC 85437-004-60

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.